Stratos Wealth Partners, Ltd. Ligand Pharmaceuticals Inc Transaction History

Stratos Wealth Partners, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$128.36 - $272.13 $378,405 - $802,239	-2,948 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$211.18 - $274.49 $9,503 - $12,352	-45 Reduced 1.5%	2,948 $809,000
Q2 2018 Aug 13, 2018	BUY	$150.77 - $207.98 $444,620 - $613,333	2,949 Added 6702.27%	2,993 $620,000
Q4 2017 Feb 09, 2018	BUY	$128.36 - $147.04 $5,647 - $6,469	44	44 $6,000

257

17.9M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.